The EPO granted and published patent EP4340708A1 for Mindtension Ltd, covering diagnostic systems and methods for attention disorders, emotional dysregulation, and impulsive dysregulation. The patent is designated in 32 European states including all major EU member states. Key IPC classifications include A61B 5/00, A61B 5/38, A61B 5/389, A61B 5/395, A61B 5/11, G16H 50/30, and A61B 5/16.

This patent publication does not impose compliance obligations on regulated entities. Medical device manufacturers or healthcare providers developing similar diagnostic technologies should review the patent claims to assess potential licensing requirements or design-around considerations. The patent grants Mindtension Ltd exclusive rights to the disclosed diagnostic methods across designated EU states.